AGNC Investment Corp. (AGNC) — Earnings Call X-Ray
Our AI read all 39 of AGNC's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
B
Q1 2025
Calls Analyzed
39
2016–2025
Avg Candor
7.3/9
evasion 2/9
Call-by-call analysis
🔒 Q2 2025 earnings call
2025-07-23
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2025 call grade is ready
The full 37-point AI read of AGNC's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
B
Q1 2025 earnings call
2025-04-22
move ±10.4%
Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: stableMargins: contractingPricing: under pressure 9 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q4 2024 earnings call
2025-01-28
move ±6.4%
Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: stableMargins: contractingPricing: stable 6 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q3 2024 earnings call
2024-10-22
move ±7.1%
Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: stableMargins: contractingPricing: stable 7 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q2 2024 earnings call
2024-07-23
move ±9.6%
Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics, relaxed under questioning.
Guidance: maintainedDemand: mixedMargins: contractingPricing: stable 6 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q1 2024 earnings call
2024-04-23
move ±6.8%
Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: stableMargins: stable 8 analysts · 15 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubtsDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q4 2023 earnings call
2024-01-23
move ±7.1%
Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics, relaxed under questioning.
Guidance: maintainedDemand: stableMargins: stablePricing: stable 5 analysts · 9 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q3 2023 earnings call
2023-10-31
move ±13.7%
Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: mixedMargins: contractingPricing: under pressure 5 analysts · 8 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubtsDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q2 2023 |
2023-07-25 |
B |
maintained | stable | expanding |
7/9 |
1/9 |
| Q1 2023 |
2023-04-25 |
B+ |
maintained | mixed | stable |
7/9 |
1/9 |
| Q4 2022 |
2023-01-31 |
B+ |
raised | accelerating | unclear |
7/9 |
2/9 |
| Q3 2022 |
2022-10-25 |
C+ |
none | slowing | contracting |
8/9 |
2/9 |
| Q2 2022 |
2022-07-26 |
A |
maintained | slowing | expanding |
8/9 |
2/9 |
| Q1 2022 |
2022-05-03 |
B |
none | unclear | contracting |
8/9 |
2/9 |
| Q4 2021 |
2022-02-01 |
B |
none | unclear | stable |
8/9 |
2/9 |
| Q3 2021 |
2021-10-26 |
B |
none | stable | expanding |
7/9 |
2/9 |
| Q2 2021 |
2021-07-27 |
B |
none | mixed | stable |
8/9 |
2/9 |
| Q1 2021 |
2021-04-27 |
B+ |
maintained | stable | stable |
7/9 |
1/9 |
| Q4 2020 |
2021-01-26 |
A |
maintained | stable | contracting |
8/9 |
2/9 |
| Q3 2020 |
2020-10-27 |
B |
maintained | stable | expanding |
7/9 |
2/9 |
| Q2 2020 |
2020-07-28 |
A |
raised | stable | expanding |
8/9 |
2/9 |
| Q1 2020 |
2020-04-30 |
B |
none | unclear | contracting |
8/9 |
2/9 |
| Q4 2019 |
2020-01-30 |
B+ |
maintained | stable | expanding |
7/9 |
2/9 |
| Q3 2019 |
2019-10-31 |
B+ |
maintained | stable | expanding |
7/9 |
2/9 |
| Q2 2019 |
2019-07-25 |
C+ |
none | unclear | contracting |
7/9 |
3/9 |
| Q1 2019 |
2019-04-25 |
C+ |
lowered | stable | contracting |
8/9 |
2/9 |
| Q4 2018 |
2019-01-31 |
C+ |
none | mixed | contracting |
7/9 |
2/9 |
| Q3 2018 |
2018-10-25 |
B |
none | stable | contracting |
7/9 |
2/9 |
| Q2 2018 |
2018-07-26 |
B |
maintained | stable | stable |
7/9 |
2/9 |
| Q1 2018 |
2018-04-26 |
A |
none | stable | expanding |
8/9 |
2/9 |
| Q4 2017 |
2018-02-01 |
A |
maintained | stable | stable |
8/9 |
1/9 |
| Q3 2017 |
2017-10-26 |
B |
none | stable | stable |
7/9 |
2/9 |
| Q2 2017 |
2017-07-27 |
B |
maintained | stable | stable |
7/9 |
2/9 |
| Q1 2017 |
2017-04-27 |
B |
none | stable | stable |
7/9 |
1/9 |
| Q4 2016 |
2017-02-02 |
B |
none | stable | contracting |
8/9 |
2/9 |
| Q3 2016 |
2016-10-25 |
B |
maintained | stable | expanding |
7/9 |
2/9 |
| Q2 2016 |
2016-07-28 |
C+ |
lowered | stable | expanding |
7/9 |
2/9 |
| Q1 2016 |
2016-04-26 |
C |
none | stable | contracting |
6/9 |
4/9 |
| Q4 2015 |
2016-02-02 |
C |
maintained | mixed | contracting |
7/9 |
4/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of AGNC's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
C+
Q3 2022 earnings call
2022-10-25
4 more research questions answered NO
C+
Q2 2016 earnings call
2016-07-28
1 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← AGN All “A” companies
AGO →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.